Evidence map›Paper›PMID 39274330›Full record

ArticleJournal of clinical medicine2024

Use of Eltrombopag to Improve Thrombocytopenia and Tranfusion Requirement in Anti-CD19 CAR-T Cell-Treated Patients.

Maria-Eva Mingot-Castellano, Juan Luis Reguera-Ortega, Denis Zafra Torres, Rafael Hernani, Oriana Lopez-Godino, Manuel Guerreiro, Blanca Herrero, Lucia López-Corral, Alejandro Luna, Lesli Gonzalez-Pinedo and 13 more

Abstract read
In one paragraph

Article in Journal of clinical medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Platelet Transfusion for Patients with Cancer: An Update.Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie · 2025
    Review
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Maria-Eva Mingot-CastellanoHospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla, IBiS/CSIC, Universidad de Sevilla, 41004 Sevilla, Spain.ORCID 0000-0001-9083-855X
Juan Luis Reguera-OrtegaHospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla, IBiS/CSIC, Universidad de Sevilla, 41004 Sevilla, Spain.ORCID 0009-0009-6408-1747
Denis Zafra TorresHospital Universitario 12 de Octubre, 28041 Madrid, Spain.
Rafael HernaniINCLIVA Health Research Institute, Hospital Clínico Universitario, 46010 Valencia, Spain.
Oriana Lopez-GodinoHematology Department, Centro Regional de Hemodonación, IMIB-Pascual Parrilla, Hospital Universitario Morales-Meseguer, 30008 Murcia, Spain.
Manuel GuerreiroServicio de Hematología, Hospital Universitario y Politécnico La Fe, 46026 Valencia, Spain.ORCID 0000-0001-5978-2578
Blanca HerreroHospital Infantil Universitario del Niño Jesús, 28009 Madrid, Spain.
Lucia López-CorralIBSAL, CIBERONC, Centro de Investigación del Cáncer-IBMCC (USAL-CSIC), Hospital Universitario de Salamanca (Spain), 37007 Salamanca, Spain.
Alejandro LunaHospital Universitario Ramón y Cajal, 28034 Madrid, Spain.ORCID 0000-0003-2201-3091
Lesli Gonzalez-PinedoHospital Universitario de Gran Canaria Dr. Negrín, 35010 Las Palmas de Gran Canaria, Spain.
Anabelle Chinea-RodriguezHospital Universitario Ramón y Cajal, 28034 Madrid, Spain.ORCID 0000-0002-6291-4612
Ana Africa-MartínIBSAL, CIBERONC, Centro de Investigación del Cáncer-IBMCC (USAL-CSIC), Hospital Universitario de Salamanca (Spain), 37007 Salamanca, Spain.
Rebeca BailenInstituto de Investigación Sanitaria Gregorio Marañón, Hospital General Universitario Gregorio Marañón, 28009 Madrid, Spain.
Nuria Martinez-CibrianHospital Clinic Barcelona, Institut de Recerca Sant Joan de Déu, Barcelona Hospital Sant Joan de Déu, 08950 Barcelona, Spain.ORCID 0000-0002-8688-1202
Pascual BalsalobreUniversity Hospital Vall d'Hebron, 08035 Barcelona, Spain.
Silvia FilaferroUniversity Hospital Vall d'Hebron, 08035 Barcelona, Spain.
Anna Alonso-SaladriguesInstitut de Recerca Sant Joan de Déu, Hospital Sant Joan de Déu, 08950 Barcelona, Spain.ORCID 0000-0002-3195-5470
Pere BarbaGrupo Español de Trasplante Hematopoyético y Terapia Celular, 28040 Madrid, Spain.
Antonio Perez-MartinezPediatric Hematology-Oncology Department, La Paz University Hospital, 28034 Madrid, Spain.ORCID 0000-0002-6436-9195
María CalbachoHospital Universitario 12 de Octubre, 28041 Madrid, Spain.ORCID 0000-0001-8106-4863
Jose Antonio Perez-SimónHospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla, IBiS/CSIC, Universidad de Sevilla, 41004 Sevilla, Spain.ORCID 0000-0003-3616-6101
Jose Maria Sánchez-PinaHospital Universitario 12 de Octubre, 28041 Madrid, Spain.ORCID 0000-0002-9181-0900
On Behalf Of The Spanish Group Of Hematopoietic Transplant And Cell Therapy Geth-Tc

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

adverse eventsCAR-Teltrombopagneutropeniapan-cytopeniaplatelet transfusionred blood cell transfusionthrombocytopeniathrombopoietin receptor agonist

Identifiers

PMID39274330
PMCPMC11396136

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.